Return On Equity of Neumora Therapeutics, Inc. from 31 Dec 2022 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Neumora Therapeutics, Inc. quarterly and annual Return On Equity in % history and change rate from 31 Dec 2022 to 30 Sep 2025.
  • Neumora Therapeutics, Inc. Return On Equity for the quarter ending 30 Sep 2025 was -114%, a 55% decline year-over-year.
  • Neumora Therapeutics, Inc. annual Return On Equity for 2024 was -69%, a 101% decline from 2023.
  • Neumora Therapeutics, Inc. annual Return On Equity for 2023 was 9737%, a 30203% increase from 2022.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)

Neumora Therapeutics, Inc. Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -114% -40% -55% 01 Jul 2025 30 Sep 2025
Q2 2025 -99% -38% -61% 01 Apr 2025 30 Jun 2025
Q1 2025 -85% +29% +25% 01 Jan 2025 31 Mar 2025
Q4 2024 -69% -9806% -101% 01 Oct 2024 31 Dec 2024
Q3 2024 -74% -141% -210% 01 Jul 2024 30 Sep 2024
Q2 2024 -61% -90% -317% 01 Apr 2024 30 Jun 2024
Q1 2024 -114% -142% -501% 01 Jan 2024 31 Mar 2024
Q4 2023 9737% +9705% +30203% 01 Oct 2023 31 Dec 2023
Q3 2023 67% 01 Jul 2023 30 Sep 2023
Q2 2023 28% 01 Apr 2023 30 Jun 2023
Q1 2023 28% 01 Jan 2023 31 Mar 2023
Q4 2022 32% 01 Oct 2022 31 Dec 2022

Neumora Therapeutics, Inc. Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2024 -69% -9806% -101% 01 Jan 2024 31 Dec 2024
2023 9737% +9705% +30203% 01 Jan 2023 31 Dec 2023
2022 32% 01 Jan 2022 31 Dec 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.